Download Citation
Article Source:
Cost-effectiveness analysis of mepolizumab among patients with severe asthma from the Chinese societal perspective
Shi C,
Wang Y,
Tan C,
Zeng X,
Liu Q
(2026)
Cost-effectiveness analysis of mepolizumab among patients with severe asthma from the Chinese societal perspective.
PLOS ONE 21(5): e0348955.
https://doi.org/10.1371/journal.pone.0348955